skip to main content

ProfessionalsJames Parkinson

James Parkinson
Counsel

Tel: +44-20-7601-8725
Fax: +44-20-7681-2895
jparkinson@paulweiss.com

Tel: +44-20-7601-8725
jparkinson@paulweiss.com
London

20 Air Street
London, United Kingdom W1B 5AN
Fax: +44-20-7681-2895

+ vCard ADD TO CONTACTS
Education 
Bar Admissions 
Education 
Bar Admissions 

James is a Counsel in the London Antitrust team, and advises clients on EU, UK and multijurisdictional merger control, foreign direct investment and EU foreign subsidies strategy and filings. James has acted for leading private equity firms, financial institutions, sovereign wealth funds, and multinational corporations in matters before the European Commission, UK Competition and Markets Authority and global antitrust and foreign direct investment agencies.

EXPERIENCE

James' select representations include: 

  • Acceleron Pharma on its $11.5 billion sale to Merck.
  • Accenture on its $830 million disposal of Navitaire to Amadeus.
  • Advent International on its $4.25 billion co-investment with Warburg Pincus in BaxterInternational Inc.’s BioPharma Solutions business.
  • Apollo Global Management on its $6.3 billion acquisition of International Game Technology's gaming and digital business IGT Gaming and Everi Holdings.
  • Bain Capital on its £414 million acquisition of Ibstock Brick and Glen Gery Corporation.
  • Bain Capital and Cinven on their €5.3 billion joint public takeover of STADA Arzneimittel.
  • Baring Private Equity Asia on:
    • its $7 billion sale to EQT Group;
    • its acquisition of Cue Group; and
    • the sale of the global surgical business of Lumenis to Boston Scientific.
  • Bloomberg on its acquisition of Broadway Technology.
  • CapVest on the carve-out acquisition from Mallinckrodt of its global nuclear imaging radiopharmaceuticals division.
  • The Carlyle Group and CITIC on their $2.08 billion acquisition of the majority stake in the master franchisee for McDonald’s in China and Hong Kong.
  • Golden Gate Capital on its:
    • $1.215 billion acquisition of ANGUS Chemical Company;
    • $2.9 billion acquisition of Neustar; and
    • $2.5 billion investment by Koch Industries in Infor, Inc.
  • McAfee Corp on the:
    • $14 billion sale of its Consumer business to an investor group comprising Advent International, Permira, Crosspoint Capital, Canada Pension Plan Investment Board, GIC and ADIA; and
    • $4 billion sale of its Enterprise division to Symphony Technology Group.
  • Solera, a digital technology group part-owned by Vista Equity Partners, on its £340 million acquisition of Autodata.
  • Spectrum Brands on its $2 billion carve-out sale of its global consumer battery business (Varta & Rayovac) to Energizer.
  • Sun Capital on its acquisition of Finlays Horticulture Investments.
  • TA Associates, Vista Equity Partners and Aptean on a strategic growth investment by Charlesbank Capital Partners.
  • TPG on its:
    • acquisition of AmSpec Group; and
    • $6.5 billion co-investment with Francisco Partners in New Relic.
  • Triton Partners on its acquisition of the tour operating activities of Corendon and its subsequent combination with Sunweb.
  • Tronox on its $2.2 billion acquisition of Cristal’s titanium dioxide business (Phase II).
  • Vista Equity Partners on:
    • its $1.6 billion acquisition of Infoblox;
    • its acquisition of joint control of Allocate Software with Hg Capital;
    • the acquisition of Farelogix Inc. by its portfolio company Accelya; and
    • its $1.65 billion acquisition of Cvent.

© 2024 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy